The Motley Fool

£1,000 to invest? I think buying this FTSE stock will make you money!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Chart showing an upwards trend, possibly in the FTSE 100
Image source: Getty Images.

Genus Plc (LSE:GNS) is a FTSE 250 company I really like the look of. Today saw the release of its interim full-year results and shares have jumped nearly 10% on the back of the positive news.

FTSE opportunity

What does an animal genetics company actually do? Genus breeds better pigs and cattle for farmers so they can produce higher quality meat and milk more efficiently. This involves a scientific and technological process involving DNA, identifying desirable characteristics and much more that a scientific mind would understand better than me. GNS also owns intellectual property for its own technology, which enhances its processes.

5 Stocks For Trying To Build Wealth After 50

Markets around the world are reeling from the coronavirus pandemic… and with so many great companies trading at what look to be ‘discount-bin’ prices, now could be the time for savvy investors to snap up some potential bargains.

But whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be a daunting prospect during such unprecedented times.

Fortunately, The Motley Fool UK analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global upheaval…

We’re sharing the names in a special FREE investing report that you can download today. And if you’re 50 or over, we believe these stocks could be a great fit for any well-diversified portfolio.

Click here to claim your free copy now!

I feel I know a good opportunity on the FTSE when I see one. Although the pandemic and ensuing market crash has battered many industries, anything linked to food, production of food, and consumer staples are safe stock options in my opinion. I firmly place Genus in this category.

When the market crashed GNS lost just over 25% of its share price value. The beginning of March saw shares trading at 3,644p per share. Fast-forward two weeks and you could pick up shares as cheap as 2,650p. Since this low point, GNS has recovered to pre-crash levels and surpassed the beginning of March price. At the time of writing, shares can be purchased at close to 3,850p per share.

FY results

This morning GNS released its FY results ending 30 June 2020. The results were impressive in my opinion especially in the midst of an economic downturn and difficult market conditions. Revenue increased 13% from £488.5m last year to £551.4m this year. Profit before tax jumped a stellar 16% from £61m to £71m. Free cash flow rose from £10m last year to £35.2m, too.

There was further good news for investors as the board maintained the dividend would be retained. Many other FTSE-listed companies have suspended or cancelled dividends to conserve cash in the crisis. GNS’s board recommended a final dividend of 19.7p per share. This is a healthy increase of 5% over the prior year final dividend. If you combined the interim dividend increase of 6%, this will result in a total dividend for the year of 29.1p per share. You can be paid this dividend in December as long as you are a shareholder on the register by close of play on 20 November 2020.

Stroke of Genus

Genus has been affected by the Covid-19 pandemic. With a global footprint and customer base, there have been logistical issues and restrictions. That said, it has not affected GNS as much as anticipated and there is a favourable outlook moving forward in the light of easing restrictions. I believe its global footprint as well as key strategic partnerships in China and the US will help continue its impressive performance.

I feel Genus is well protected as there will always be demand for food products, especially staples such as meat and milk. Although the share price is not the cheapest, full-year results show GNS has performed well against the backdrop of the Covid-19 pandemic and downturn. There is also a dividend to be paid out which has increased on last year too. I would not be surprised if the share price rose further still as other FTSE counterparts are still struggling.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Jabran Khan has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.